IARC Monographs Volume 118: Welding, Welding Fumes, and Some Related Chemicals
21-28 March 2017
See more information
16/03/2017 The International Agency for Research on Cancer (IARC) is proud to be a partner in the WICC Network, which is hosted by Menzies School of Health Research, Australia. The WICC Network is dedicated to improving cancer outcomes for Indigenous peoples around the world. It was established to continue research collaboration after the World Indigenous Cancer Conference (WICC), which was held in Brisbane, Australia, in 2016. Read more
The International Agency for Research on Cancer (IARC) is aware that the Committee for Risk Assessment of the European Chemicals Agency (ECHA) has concluded that the available scientific evidence did not meet the criteria of the Classification, Labelling and Packaging (CLP) Regulation required to classify glyphosate as a carcinogen or as genotoxic.
The international experts composing the IARC Monograph Working Group, which evaluated glyphosate in March 2015, concluded that glyphosate is probably carcinogenic to humans based on the publicly available scientific evidence on epidemiology, animal carcinogenicity, and carcinogenic mechanisms, using the methodology described in detail in the IARC Monographs preamble.
The IARC evaluation of glyphosate is not affected by the ECHA review. IARC does not comment on the expertise, methodology, or conclusions of other national or international committees. Read more, Q&A on Glyphosate
Affordable vaccines key to scale up HPV vaccination and prevent thousands of avoidable cervical cancers
02/02/2017 Read more
WHO/IARC Classification of Tumours, 4th Edition, Volume 9: WHO Classification of Head and Neck Tumours
The WHO Classification of Head and Neck Tumours is the ninth volume in the 4th Edition of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies evaluating response to therapy and clinical outcome.
Diagnostic criteria, pathological features, and associated genetic alterations are described in a disease-oriented manner. Sections on all recognized neoplasms and their variants include new ICD-O codes, epidemiology, clinical features, macroscopy, pathology, genetics, and prognosis and predictive factors.